 |
 |
| Anthony (“Tony”) P. Deasey | Chief Financial Officer |  |
|
Over the last 20 years Mr. Deasey has served as Chief Financial Officer of five companies including three public and two privately held companies. Since starting his career in public accounting with Price Waterhouse in London, England, Tony has built a broad global financial and operational experience base across several industries.
Most recently, Tony served as Chief Financial Officer of Northwest Biotherapeutics, Inc. a biotech company focused on the development of personal dendritic cell based vaccines to treat a variety of cancer indications. Prior to Northwest Biotherapeutics Tony served as Chief Financial and Chief Operating Officer of Celsion Corporation where he led the transformation of the company from a medical device company to a fully fledged drug development company in late stage trials to treat primary liver cancer. Before joining Celsion Tony had been Chief Financial Officer of World Kitchen Inc., Rollerblade Inc. and Church & Dwight Co. Inc. and had served in increasingly senior positions in Chesebrough Ponds and Unilever. | |